Clinical trial
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal…
NCT00426049 · German Heart Institute, Other · Unknown status
Key facts
| NCT number | NCT00426049 |
|---|---|
| Title | Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation |
| Official title | Monocenter, Double Blinded, Prospective, Randomized Placebo Controlled Study Investigating Prevention of Major Adverse Cardiac Events (MACEs) Within 6 Months by Systemic Treatment With Everolimus After Coronary Intervention With Bare Metal Stents in Patients With Significant Coronary Artery Disease |
| Lead sponsor | German Heart Institute, Other |
| Collaborators | Novartis Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Coronary Restenosis |
| Intervention type | Drug |
| Interventions | Everolimus |
| Enrollment | 484 |
| Start date | Oct 1, 2006 |
| First posted | Jan 24, 2007 |
| Last update posted | Jan 24, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: